| Analysis | Metabolite Name | Measured Value | Units | Exercise | Group | Sex | Type |
|---|---|---|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 1185 | Peak area normalized | No | LowRisk | Male | Non-invasive |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 1218 | Peak area normalized | No | Normal Pressures | Female | Cath |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 1346 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 1573 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 1586 | Peak area normalized | No | Healthy | Female | Non-invasive |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 1650 | Peak area normalized | No | Healthy | Female | Non-invasive |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 1839 | Peak area normalized | Yes | PAH | Female | Cath |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 1985 | Peak area normalized | Yes | PAH | Female | Cath |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 1989 | Peak area normalized | No | Borderline Pressures | Female | Cath |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 2073 | Peak area normalized | Yes | Borderline Pressures | Male | Cath |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 2181 | Peak area normalized | No | Healthy | Male | Non-invasive |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 2244 | Peak area normalized | No | Normal Pressures | Female | Cath |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 2510 | Peak area normalized | Yes | PAH | Female | Cath |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 2517 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 2605 | Peak area normalized | No | Borderline Pressures | Male | Cath |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 2647 | Peak area normalized | No | Borderline Pressures | Male | Cath |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 3015 | Peak area normalized | No | Healthy | Female | Non-invasive |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 3084 | Peak area normalized | Yes | Healthy | Male | Non-invasive |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 3212 | Peak area normalized | No | Borderline Pressures | Female | Cath |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 3397 | Peak area normalized | No | Borderline Pressures | Male | Cath |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 3419 | Peak area normalized | No | LowRisk | Female | Non-invasive |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 3474 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 3482 | Peak area normalized | No | Healthy | Female | Non-invasive |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 3532 | Peak area normalized | Yes | Healthy | Male | Non-invasive |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 3627 | Peak area normalized | No | LowRisk | Female | Non-invasive |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 3866 | Peak area normalized | No | PAH | Female | Cath |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 4034 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 4054 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 4112 | Peak area normalized | No | PAH | Male | Cath |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 4145 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 4207 | Peak area normalized | No | PAH | Female | Cath |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 4230 | Peak area normalized | Yes | PAH | Male | Cath |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 4502 | Peak area normalized | Yes | PAH | Female | Cath |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 4601 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 4615 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 4747 | Peak area normalized | No | LowRisk | Female | Non-invasive |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 4911 | Peak area normalized | No | PAH | Male | Cath |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 5006 | Peak area normalized | No | Healthy | Male | Non-invasive |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 5018 | Peak area normalized | No | Healthy | Male | Non-invasive |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 5143 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 5160 | Peak area normalized | Yes | PAH | Female | Cath |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 5324 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 5644 | Peak area normalized | No | Healthy | Female | Non-invasive |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 5819 | Peak area normalized | No | Healthy | Female | Non-invasive |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 5880 | Peak area normalized | Yes | Borderline Pressures | Male | Cath |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 5917 | Peak area normalized | No | Healthy | Female | Non-invasive |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 6074 | Peak area normalized | No | Borderline Pressures | Female | Cath |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 7062 | Peak area normalized | No | LowRisk | Female | Non-invasive |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 7528 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 7757 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 7966 | Peak area normalized | No | LowRisk | Female | Non-invasive |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 8215 | Peak area normalized | No | LowRisk | Female | Non-invasive |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 8336 | Peak area normalized | Yes | PAH | Male | Cath |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 8504 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 8783 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 9782 | Peak area normalized | No | LowRisk | Female | Non-invasive |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 10248 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 10944 | Peak area normalized | No | Healthy | Female | Non-invasive |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 12439 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 13014 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 13107 | Peak area normalized | No | Healthy | Female | Non-invasive |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 18342 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 18887 | Peak area normalized | No | Borderline Pressures | Female | Cath |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 20168 | Peak area normalized | No | Normal Pressures | Female | Cath |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 20629 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 21178 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 22532 | Peak area normalized | No | Normal Pressures | Female | Cath |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 27548 | Peak area normalized | No | Borderline Pressures | Female | Cath |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 31585 | Peak area normalized | No | PAH | Female | Cath |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | 35031 | Peak area normalized | Yes | PAH | Female | Cath |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | Peak area normalized | No | Borderline Pressures | Female | Cath | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | Peak area normalized | No | Healthy | Female | Non-invasive | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | Peak area normalized | No | Healthy | Male | Non-invasive | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | Peak area normalized | No | LowRisk | Female | Non-invasive | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | Peak area normalized | No | LowRisk | Male | Non-invasive | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | Peak area normalized | No | Normal Pressures | Female | Cath | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | Peak area normalized | No | Normal Pressures | Male | Cath | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | Peak area normalized | No | PAH | Female | Cath | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | Peak area normalized | No | PAH | Male | Cath | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | Peak area normalized | Yes | Borderline Pressures | Female | Cath | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | Peak area normalized | Yes | Borderline Pressures | Male | Cath | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | Peak area normalized | Yes | Healthy | Female | Non-invasive | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | Peak area normalized | Yes | Healthy | Male | Non-invasive | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | Peak area normalized | Yes | LowRisk | Female | Non-invasive | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | Peak area normalized | Yes | LowRisk | Male | Non-invasive | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | Peak area normalized | Yes | Normal Pressures | Female | Cath | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | Peak area normalized | Yes | Normal Pressures | Male | Cath | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | Peak area normalized | Yes | PAH | Female | Cath | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M-H)- | Peak area normalized | Yes | PAH | Male | Cath |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|